I think it has potential for modest growth. Personally I like companies that hold the product solely as it leaves room for upside. But having little to no cost risk going forward with lead product as merck is financing leaves it pretty stable. lots of cash to move on to next projects. It has a lot of things I look for. institution, insider, cash, somewhat undervalued, phase 3.